Brain atrophy measurements should be used to guide therapy monitoring in MS – NO

Frederik Barkhof

doi:10.1177/1352458516649452

June 22, 2016Multiple Sclerosis JournalOpen Access

Brain atrophy measurements should be used to guide therapy monitoring in MS – NO

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Frederik Barkhof (2016) studied this question.

synapsesocial.com/papers/6ab39a29a3c00347e1b7b955 https://doi.org/10.1177/1352458516649452

View Full Paper

Ask AI

Bookmark

Share

Brain atrophy measurements should be used to guide therapy monitoring in MS – NO

Ask about this paper

Abstract

Discussion

Cite This Study

Brain atrophy measurements should be used to guide therapy monitoring in MS – NO

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading